Modulation of acetylcholine receptor expression in seronegative myasthenia gravis

Annals of Neurology

Volumn 48, Issue 5, 2000, Pages 696-705

  Poea, Sandrine ^a   Guyon, Thierry ^b   Bidault, Jocelyne ^a   Bruand, Corinne ^a   Mouly, Vincent ^c   Berrih Aknin, Sonia ^a  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^b Institut de Recherche Jouveinal   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; IMMUNOGLOBULIN G; MESSENGER RNA;

ADOLESCENT; ADULT; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUSCLE BIOPSY; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEPTOR DENSITY; RECEPTOR GENE; RECEPTOR UPREGULATION;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLES; MYASTHENIA GRAVIS; RECEPTORS, CHOLINERGIC; RNA, MESSENGER;

EID: 0033767738     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200011)48:5<696::AID-ANA2>3.0.CO;2-S     Document Type: Article

References (39)

1. Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates, and diagnostic value
2. Immunology of acetylcholine receptors in relation to myasthenia gravis
3. Neuromuscular junction in myasthenia gravis: Decreased acetylcholine receptors
4. The nicotinic cholinergic receptor: Correlation of molecular structure with functional properties
5. Nicotinic receptor of acetylcholine: Structure of an oligomeric integral membrane protein
6. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor
7. Pathological mechanisms in experimental autoimmune myasthenia gravis II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptor antibodies
8. Myasthenia gravis: Passive transfer from man to mouse
9. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis
10. Antigenic modulation of human myotube acetylcholine receptor by myasthenic sera. Serum titer determines receptor internalization rate
11. Myasthenia gravis without acetylcholine receptor antibody: A disease entity
12. Seronegative myasthenia gravis A plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM
13. Plasma from patients with seronegative myasthenia gravis inhibit nAChR responses in the TE671/RD cell line
14. Purified IgG from seropositive and seronegative patients with myasthenia gravis reversibly blocks currents through nicotinic acetylcholine receptor channels
15. Plasma from myasthenia gravis patients reduces acetylcholine receptor agonist-induced Na+ flux into TE671 cell line
16. Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidence for a compensatory mechanism triggered by receptor loss
17. Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against antigenic modulation caused by myasthenic sera
18. Le dosage des anticorps anti-recepteurs de l'acetylcholine dans la myasthenie. Etude de 329 serums
19. Myasthenia gravis: Evaluation of treatment in 1355 patients
20. Thymic hyperplasia and neoplasia: A review of current concepts
21. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
22. Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction
23. Decrease in acetylcholine-receptor content of human myotube cultures mediated by monoclonal antibodies to alpha, beta and gamma subunits
24. Seronegative myasthenia gravis: Evidence for plasma factor(s) interfering with acetylcholine receptor function
25. Passive transfer of seronegative myasthenia gravis to mice
26. Localization of nicotinic acetylcholine receptor alpha-subunit transcripts during myogenesis and motor endplate development in the chick
27. Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non-AChR ligands: Possible relevance to seronegative myasthenia gravis
28. Effect of Graves' IgG on gene transcription in human thyroid cell cultures. Thyroglobulin gene activation
29. Protein-tyrosine phosphatases specifically regulate muscle adult-type nicotinic acetylcholine receptor gene expression
30. Functional modulation of the nicotinic acetylcholine receptor by tyrosine phosphorylation
31. Determination of the tyrosine phosphorylation sites of the nicotinic acetylcholine receptor
32. Desensitization of acetylcholine receptors in rat myotubes is enhanced by agents that elevate intracellular cAMP
33. The evidence of accelerative interaction between cAMP-dependent protein kinase and external calcium for the desensitization of nicotinic acetylcholine receptor channel in mouse skeletal muscle cells
34. Heregulin-stimulated acetylcholine receptor gene expression in muscle: Requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity
35. Rapsyn is required for MuSK signaling and recruits synaptic components to a MuSK-containing scaffold
36. The synapse-associated protein rapsyn regulates tyrosine phosphorylation of proteins colocalized at nicotinic acetylcholine receptor clusters
37. Functional interaction of Src family kinases with the acetylcholine receptor in C2 myotubes
38. Binding of the nicotinic acetylcholine receptor to SH2 domains of Fyn and Fyk protein tyrosine kinases
39. Tyrosine phosphorylation of nicotinic acetylcholine receptor mediates Grb2 binding